Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: The impact of DPP-4 inhibitors on long-term survival among diabetic patients after first acute myocardial infarction

Fig. 1

Flowchart outlining the various study cohorts. There were 186,326 patients in Taiwan between January 2000 and December 2012 with a primary diagnosis of acute myocardial infarction (AMI) (ICD codes: 410–410.92). From this group, patients were excluded who had a previous admission for AMI, who were ≤18 or ≥120 years old, and whose gender was undetermined. Among the remaining 186,112 cases with a primary diagnosis AMI, 72,924 cases had diabetes mellitus and underwent propensity score matching to controls to minimize baseline differences between the two groups. 2672 AMI patients with DPP-4i and 2672 matched controls were, therefore, included in our final analysis. AMI acute myocardial infarction, DM diabetes mellitus, DPP-4 dipeptidyl peptidase 4, PCI percutaneous coronary intervention

Back to article page